CORC

在结果中检索

CORC

浏览/检索结果: 共18条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Safety and Efficacy, Including Event-Free Survival, of Deferasirox Versus Placebo in Iron-Overloaded Patients with Low- and Int-1-Risk Myelodysplastic Syndromes (MDS): Outcomes from the Randomized, Double-Blind Telesto Study 会议论文
60th Annual Meeting of the American-Society-of-Hematology (ASH), DEC 01-04, 2018
作者:  Angelucci, Emanuele;  Li, Junmin;  Greenberg, Peter L.;  Depei, Wu;  Hou, Ming
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/31
Effects of arsenic disulfide on apoptosis, histone acetylation, toll like receptor 2 activation, and erythropoiesis in bone marrow mononuclear cells of myelodysplastic syndromes patients in vitro 期刊论文
LEUKEMIA RESEARCH, 2017, 卷号: 62
作者:  Xu, Ming;  Ren, Jian-ye;  Guo, Yuan-cheng;  Xu, Bai-xue;  Zeng, Qing
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05
Effects of arsenic disulfide on apoptosis, histone acetylation, toll like receptor 2 activation, and erythropoiesis in bone marrow mononuclear cells of myelodysplastic syndromes patients in vitro 期刊论文
Leukemia research, 2017, 卷号: 62, 页码: 4-11
作者:  Xu Ming[1];  Ren Jian-Ye[2];  Guo Yuan-Cheng[3];  Xu Bai-Xue[4];  Zeng Qing[5]
收藏  |  浏览/下载：3/0  |  提交时间：2019/04/26
Apoptosis in human myelodysplastic syndrome CD34+cells is modulated by the upregulation of TLRs and histone H4 acetylation via a beta-arrestin 1 dependent mechanism 期刊论文
EXPERIMENTAL CELL RESEARCH, 2016, 卷号: 340, 期号: 1
作者:  Zeng, Qing;  Shu, Jing;  Hu, Qi;  Zhou, Shao-Hong;  Qian, Yi-Ming
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
The prevalence of chromosomal aberrations associated with myelodysplastic syndromes in China 期刊论文
ANNALS OF HEMATOLOGY, 2016, 卷号: 95, 期号: 8
作者:  Hu, Qinyong;  Chu, Yuxin;  Song, Qibin;  Yao, Yi;  Yang, Weihong
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05
Decitabine for Treatment of Myelodysplastic Syndromes in Chinese Patients: An Open-Label, Phase-3b Study. 期刊论文
Advances in therapy, 2015, 卷号: 32, 期号: [db:dc_citation_issue], 页码: 1140-59
作者:  Wu Depei;  Du Xin;  Jin Jie;  Xiao Zhijian;  Shen Zhixiang
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/02
TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases 期刊论文
Journal of Hematology & Oncology, 2015, 卷号: 8, 期号: 1, 页码: 45
作者:  Ok, Chi Young;  Patel, Keyur P;  Garcia-Manero, Guillermo;  Routbort, Mark J;  Peng, Jie
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/03
Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases 期刊论文
Leukemia Research, 2015, 卷号: 39, 期号: 3, 页码: 348-354
作者:  Ok, Chi Young;  Patel, Keyur P.;  Garcia-Manero, Guillermo;  Routbort, Mark J.;  Fu, Bin
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/03
A systematic classification of megakaryocytic dysplasia and its impact on prognosis for patients with myelodysplastic syndromes 期刊论文
2015, 卷号: 5, 页码: 12
作者:  Feng Gege;  Gale Robert Peter;  Cui Wen;  Cai Wenyu;  Huang Gang
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04
PHARMACOKINETICS (PK) OF SUBCUTANEOUS (SC) AZACITIDINE (AZA) IN CHINESE SUBJECTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES (HR-MDS) FROMA PHASE II, OPEN-LABEL STUDY. 会议论文
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015-02-01
作者:  Laille, E.;  Xiao, Z.;  Du, X.;  Dong, Q.;  Songer, S.
收藏  |  浏览/下载：1/0  |  提交时间：2020/01/13

©版权所有 ©2017 CSpace - Powered by CSpace